Senseonics Q2 revenue $6.6M (+37% YoY); net loss narrows to $14.5M

Senseonics Holdings, Inc.

2025-Q2 EPS reported -$0.04 revenue$12,906,000

Revenue $6.6M, up 37% YoY, driven by 79% U.S. new patient starts growth to $4.9M.
Net loss $14.5M ($0.02 loss per share) vs $20.3M loss in Q2 2024; gross profit $3.1M vs $0.3M.
FY2025 revenue guidance reaffirmed at $34-38M; gross margins expected 32.5%-37.5%.
Raised $77.8M gross proceeds ($57.5M public offering + $20.3M Abbott private placement).
Entered development agreement with Sequel Med Tech to integrate Eversense 365 with twiist AID system.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.